AzTrials
AzTrials

Concussion (Diagnosis)DRAK-CARENCT07341880

Longitudinal Monitoring of Head Impacts in Elite Junior Ice Hockey

An observational study of Concussion (Diagnosis) and Sport-related Concussion, run by University Hospital, Caen at 1 site in France.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This study aims to better understand how head impacts during ice hockey affect the brain and body, especially in young athletes. Even when players do not show clear signs of concussion, these repeated impacts may cause subtle changes in the brain's structure and in how the body regulates basic functions, such as heart… Read more about this study

Who is it for?
Ages 13 to 18 yearsHealthy volunteers can take part
What is being tested?
Head impact monitoring, Heart rate variability monitoring and Dual-task cognitive and motor assessment
Type of treatment
Medical device
How many people
52 participants
Where
1 siteFrance
Study dates
3 Sep 2025to Jun 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 18 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Study population: The study population consists of licensed junior ice hockey players from the Hockey Club of Caen, competing in the U15 and U18 categories. These athletes regularly participate in competitive games and practices throughout the season and represent a cohort of developing players exposed to repeated head impacts in a real-world sports setting.

Who may be able to join

  • Licensed athletes from the Hockey Club of Caen, playing in the U15 or U18 teams.

Who cannot join

  • Inability of the participant or their legal representative to receive study information or comply with study requirements.
  • Participant or legal representative cannot be reached (in person, by phone, or by email) during the sports season.
  • Refusal of the participant or their legal representative to participate in the study.

Trial locations and contacts

1 site in 1 country.

France1 site
  • Centre Hospitalo-Universitaire de Caen Normandie

    Caen, Normandy

Other trials in France

About this study

This study aims to better understand how head impacts during ice hockey affect the brain and body, especially in young athletes. Even when players do not show clear signs of concussion, these repeated impacts may cause subtle changes in the brain's structure and in how the body regulates basic functions, such as heart rhythm and attention.

This study will follow elite junior ice hockey players over the course of one full season to better understand the effects of repeated head impacts. Using a small helmet sensor (Bearmind) and video analysis, researchers will record and analyze every head impact that occurs during games and practices.

Read more

Three times during the season - before, mid-season, and after - players will complete assessments of heart rate variability (using Polar H10 monitors) and a dual-task test that measures attention and coordination.

After any diagnosed concussion, players will be reassessed with both heart rate variability and dual-task testing at 3 days post-injury. Following that, dual-task testing alone will be repeated every 3 days until return to sport. Players who experience a severe head impact, as detected by the helmet sensor, will also be evaluated 3 days after the impact with both heart rate variability and dual-task testing, even if no concussion symptoms are present.

By combining these measures, the study aims to detect early physiological and cognitive changes following head impacts, improve understanding of sub-concussive effects, and support better prevention and management strategies for young athletes.

Being tested
Head impact monitoring, Heart rate variability monitoring, Dual-task cognitive and motor assessment
Medical subject headings
Brain Concussion, Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Head impact monitoringDevice

    Players wear a helmet-mounted sensor (Bearmind) during games and practices to record and quantify head impacts.

  • Heart rate variability monitoringOther

    Players wear a Polar H10 heart rate monitor to measure heart rate variability at designated times during the season. HRV is assessed pre-, mid-, and post-season, and again 3 days after a diagnosed concussion or sever head impact to evaluate autonomic nervous system responses.

  • Dual-task cognitive and motor assessmentOther

    Players perform a dual-task test combining cognitive and motor activities while wearing a chest-mounted sensor to capture movement and performance metrics. Assessments are conducted pre-, mid-, and post-season, 3 days after a concussion or severe impact , and every 3 days until return to sport after a concussion.

Study groups in NCT07341880
Study groupRoleWhat they receive
Young Hockey PlayersElite junior ice hockey players will be monitored over one full season. Each player will wear a helmet sensor (Bearmind) to record head impacts. Heart rate variability (Polar H10) and dual-task tests will be conducted pre-, mid-, and post-season. After any concussion, both measures will be repeated at 3 days post-injury, with dual-task testing every 3 days until return to sport. Following a severe head impact, assessments will occur 3 days post-impact.
Receives: Device: Head impact monitoring; Other: Heart rate variability monitoring; Other: Dual-task cognitive and motor assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Head impact exposure

    Head impacts will be recorded using the Bearmind helmet-mounted sensor during all games and practices over the competitive season.

    Measured: Continuously throughout one full competitive season during all games and practices (up to 9 months)

Secondary outcomes (3)
  1. Heart rate variability (HRV) using a 12-minute protocol

    HRV will be measured with the Polar H10 monitor during a standardized 12-minute protocol including three phases: resting (5 min), standing (5 min), and isometric contraction (2 min). Measures will assess autonomic nervous system responses at baseline, mid-season, post-season, and post-injury.

    Measured: At baseline, at mid-season (14 weeks from baseline), at end of season (up to 9 months from baseline), and within 5 days following a diagnosed concussion or severe head impact.

  2. Dual-task cognitive and motor performance

    A dual-task test combining cognitive and motor activities will be performed while players wear a chest-mounted sensor to capture movement accuracy and reaction metrics.

    Measured: At baseline, at mid-season (14 weeks from baseline), at end of season (up to 9 months from baseline), and within 5 days following a diagnosed concussion or severe head impact.

  3. Sport Concussion Assessment Tool (SCAT6) score

    The Sport Concussion Assessment Tool-6 (SCAT6) will be used to evaluate concussion-related symptoms, cognitive function, and balance. Assessments will be administered under standardized conditions to monitor baseline values and post-injury recovery.

    Measured: At baseline, and at 1 day and 4 days post-injury following a diagnosed concussion or severe head impact.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jan 2026
  2. Study start3 Sep 2025
  3. Primary completionMay 2026 (estimated)
  4. Study completionJun 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
52 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07341880
Sponsor's protocol ID
DRAK-CARE
Acronym
DRAK-CARE
Status last verified
Jan 2026
First submitted
28 Nov 2025
Last updated
14 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Concussion (Diagnosis) and Sport-related Concussion, run by University Hospital, Caen at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 14 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Head impact exposure (time frame: Continuously throughout one full competitive season during all games and practices (up to 9 months)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in